Global Auto Injectors Market

Auto-Injectors Market (Product Types: Prefilled and Fillable Auto-injectors; Therapeutic Applications: Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis and Others; Manufacturing Design: Standardized and Customized Auto-injectors) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

  • Rep Id : TMRGL4199
  • Published On : Mar 2015
  • No. of Pages : 89
  • Category : Healthcare

 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Auto-injectors Market
2.2 Comparative Analysis: Global Auto-injectors Market, by Geography, 2013 & 2020 (Value %)
 
Chapter 3 Global Auto-injectors Market Overview
3.1 Introduction
3.2 Market Dynamics
      3.2.1 Market Drivers
              3.2.1.1 Rising Prevalence of Anaphylaxis in Developed Countries is Increasing the Demand for Epinephrine Auto-injectors
              3.2.1.2 Favorable Reimbursement Policies are Encouraging Patients to Opt for Auto-injectors
              3.2.1.3 Efforts by Government Bodies and Market Players to Increase Awareness about the Use and Efficacy of Auto-injectors
      3.2.2 Market Restraints
              3.2.2.1 High Product Prices Restrict Patients in Emerging Economies from Purchasing Auto-injectors
      3.2.3 Market Opportunities
              3.2.3.1 High Prevalence of Food Allergies and Rheumatoid Arthritis in Emerging Economies would Drive the Demand for Auto-injectors in Asia Pacific and RoW markets
3.3 Regulatory Framework: Global Auto-injectors Market
3.4 Event Impact Analysis: Global Auto-injectors Market
3.5 Value Chain Analysis: Global Auto-injectors Market
3.6 Porter’s Five Forces Analysis: Global Auto-injectors Market
      3.6.1 Bargaining Power of Suppliers
      3.6.2 Bargaining Power of Buyers
      3.6.3 Threat of Substitutes
      3.6.4 Threat of New Entrants
      3.6.5 Competitive Rivalry
3.7 Market Attractiveness Analysis: Global Auto-injectors Market, by Geography
3.8 Competitive Landscape
      3.8.1 Market Share Analysis: Global Standardized Auto-injectors Market, by Key Players, 2013 (Value %)
 
Chapter 4 Global Auto-injectors Market, by Product Type
4.1 Introduction
4.2 Prefilled (Disposable) Auto-injectors
      4.2.1 Global Prefilled Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
4.3 Fillable (Reusable) Auto-injectors
      4.3.1 Global Fillable Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 5 Global Auto-injectors Market, by Manufacturing Design
5.1 Introduction
5.2 Standardized Auto-injectors
      5.2.1 Global Standardized Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
5.3 Customized Auto-injectors
      5.3.1 Global Customized Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 6 Global Auto-injectors Market, by Therapeutic Application
6.1 Introduction
6.2 Anaphylaxis
      6.2.1 Global Anaphylaxis Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
6.3 Multiple Sclerosis
      6.3.1 Global Multiple Sclerosis Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
6.4 Rheumatoid Arthritis
      6.4.1 Global Rheumatoid Arthritis Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
6.5 Others
      6.5.1 Global Others Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 7 Global Auto-injectors Market, by Geography
7.1 Introduction
7.2 North America
      7.2.1 North America Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
7.3 Europe
      7.3.1 Europe Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
7.4 Asia Pacific
      7.4.1 Asia Pacific Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
7.5 Rest of the World (RoW)
      7.5.1 Rest of the World Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 8 Recommendations
8.1 Invest in Emerging Economies such as India and China
8.2 Investing in Marketing Campaigns to Elevate Customer Awareness
8.3 Developing Innovative Auto-injectors
 
Chapter 9 Company Profiles
9.1 Antares Pharma, Inc.
      9.1.1 Company Overview
      9.1.2 Financial Overview
      9.1.3 Product Portfolio
      9.1.4 Business Strategies
      9.1.5 Recent Developments
9.2 Becton, Dickinson & Company
      9.2.1 Company Overview
      9.2.2 Financial Overview
      9.2.3 Product Portfolio
      9.2.4 Business Strategies
      9.2.5 Recent Developments
9.3 Biogen Idec
      9.3.1 Company Overview
      9.3.2 Financial Overview
      9.3.3 Product Portfolio
      9.3.4 Business Strategies
      9.3.5 Recent Developments
9.4 Mylan, Inc.
      9.4.1 Company Overview
      9.4.2 Financial Overview
      9.4.3 Product Portfolio
      9.4.4 Business Strategies
      9.4.5 Recent Developments
9.5 Novartis International AG
      9.5.1 Company Overview
      9.5.2 Financial Overview
      9.5.3 Product Portfolio
      9.5.4 Business Strategies
      9.5.5 Recent Developments
9.6 Pfizer, Inc.
      9.6.1 Company Overview
      9.6.2 Financial Overview
      9.6.3 Product Portfolio
      9.6.4 Business Strategies
      9.6.5 Recent Developments
9.7 Sanofi
      9.7.1 Company Overview
      9.7.2 Financial Overview
      9.7.3 Product Portfolio
      9.7.4 Business Strategies
      9.7.5 Recent Developments
9.8 Scandinavian Health Ltd (SHL) Group
      9.8.1 Company Overview
      9.8.2 Financial Overview
      9.8.3 Product Portfolio
      9.8.4 Business Strategies
      9.8.5 Recent Developments
9.9 Unilife Corporation
      9.9.1 Company Overview
      9.9.2 Financial Overview
      9.9.3 Product Portfolio
      9.9.4 Business Strategies
      9.9.5 Recent Developments
9.10 Ypsomed Holding AG
      9.10.1 Company Overview
      9.10.2 Financial Overview
      9.10.3 Product Portfolio
      9.10.4 Business Strategies
      9.10.5 Recent Developments

List of Tables
 
TABLE 1 Market Snapshot: Global Auto-injectors Market
TABLE 2 Global Auto-injectors Market Revenue, by Product Type, 2012 – 2020 (USD Million)
TABLE 3 Global Auto-injectors Market Revenue, by Manufacturing Design, 2012 – 2020 (USD Million)
TABLE 4 Major Auto-injectors Brand with Therapeutic Applications
TABLE 5 Global Auto-Injectors Market Revenue, by Therapeutic Application, 2012 – 2020 (USD Million)
TABLE 6 Global Auto-injectors Market Revenue, by Geography, 2012 – 2020 (USD Million)

List of Figures
 
FIG. 1 Auto-injectors Market Segmentation
FIG. 2 Global Auto-injectors Market, by Product Type and by Manufacturing Design, 2013 (USD Million)
FIG. 3 Global Auto-injectors Market, by Therapeutic Applications, 2013 (USD Million)
FIG. 4 Comparative Analysis: Global Auto-injectors Market, by Geography, 2013 & 2020 (Value %)
FIG. 5 Value Chain Analysis: Global Auto-injectors Market
FIG. 6 Porter’s Five Forces Analysis: Global Auto-injectors Market
FIG. 7 Market Attractiveness Analysis: Global Auto-injectors Market, by Geography
FIG. 8 Market Share Analysis: Global Standardized Auto-injectors Market, by Key Players, 2013 (Value %)
FIG. 9 Global Prefilled Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 10 Global Fillable Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 11 Global Standardized Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 12 Global Customized Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 13 Global Anaphylaxis Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 14 Global Multiple Sclerosis Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 15 Global Rheumatoid Arthritis Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 16 Global Others Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 17 North America Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 18 Europe Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 19 Asia Pacific Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 20 Rest of the World Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 21 Antares Pharma, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 22 Becton, Dickinson & Company: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 23 Biogen Idec: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 24 Mylan, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 25 Novartis International AG: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 26 Pfizer, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 27 Sanofi: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 28 Unilife Corporation: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 29 Ypsomed Holding AG: Annual Revenue, 2011 – 2013 (USD Million)